When comparing the systemic bioavailability, we observed an overall decreasing trend in AUC 0–∞ but an increasing trend in C max from lower doses (3 mg) to higher dose (12 mg).
← all excerpts
Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania.
1
—
—